Speaker Details

Kenneth Y. Tsai, MD, PhD, FAAD

Kenneth Y. Tsai, MD, PhD, FAAD

SESSIONS

S002 Updates in Cutaneous Oncology
Mar 27, 2026 • 9:00 AM - 12:00 PM • Mile High 3A
S046 What's New in Dermatopathology
Mar 29, 2026 • 1:00 PM - 4:00 PM • Bluebird 3A
F068 Journal Watching
Mar 29, 2026 • 3:30 PM - 5:30 PM • Bluebird 3E
S050 The 2026 Debates: Controversies in Dermatology
Mar 30, 2026 • 9:00 AM - 12:00 PM • Bluebird 3E

DISCLOSURES

3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); Ankyra Therapeutics – Independent Contractor(Grants/Research Funding); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);